The clinical trial of IV phase of acute ST segment elevation myocardial infarction treated with recombinant human urokinase (Pu Youke) injection

Trial Profile

The clinical trial of IV phase of acute ST segment elevation myocardial infarction treated with recombinant human urokinase (Pu Youke) injection

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 May 2016

At a glance

  • Drugs Urokinase (Primary)
  • Indications Myocardial infarction
  • Focus Therapeutic Use
  • Sponsors Shanghai Tasly Pharmaceutical
  • Most Recent Events

    • 25 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top